These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 19536908)

  • 1. Duloxetine in obese binge eater outpatients: preliminary results from a 12-week open trial.
    Leombruni P; Lavagnino L; Gastaldi F; Vasile A; Fassino S
    Hum Psychopharmacol; 2009 Aug; 24(6):483-8. PubMed ID: 19536908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful duloxetine treatment of a binge eating disorder: a case report.
    Bernardi S; Pallanti S
    J Psychopharmacol; 2010 Aug; 24(8):1269-72. PubMed ID: 19010975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pragmatic 12-week, randomized trial of duloxetine versus generic selective serotonin-reuptake inhibitors in the treatment of adult outpatients in a moderate-to-severe depressive episode.
    Martinez JM; Katon W; Greist JH; Kroenke K; Thase ME; Meyers AL; Edwards SE; Marangell LB; Shoemaker S; Swindle R
    Int Clin Psychopharmacol; 2012 Jan; 27(1):17-26. PubMed ID: 22027844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Citalopram in the treatment of binge-eating disorder: a placebo-controlled trial.
    McElroy SL; Hudson JI; Malhotra S; Welge JA; Nelson EB; Keck PE
    J Clin Psychiatry; 2003 Jul; 64(7):807-13. PubMed ID: 12934982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, double-blind, placebo-controlled study of sibutramine in the treatment of binge-eating disorder.
    Appolinario JC; Bacaltchuk J; Sichieri R; Claudino AM; Godoy-Matos A; Morgan C; Zanella MT; Coutinho W
    Arch Gen Psychiatry; 2003 Nov; 60(11):1109-16. PubMed ID: 14609886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 12 to 24 weeks pilot study of sertraline treatment in obese women binge eaters.
    Leombruni P; Pierò A; Brustolin A; Mondelli V; Levi M; Campisi S; Marozio S; Abbate-Daga G; Fassino S
    Hum Psychopharmacol; 2006 Apr; 21(3):181-8. PubMed ID: 16625525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-response relationship of duloxetine in placebo-controlled clinical trials in patients with major depressive disorder.
    Bech P; Kajdasz DK; Porsdal V
    Psychopharmacology (Berl); 2006 Oct; 188(3):273-80. PubMed ID: 16960699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duloxetine in the treatment of binge eating disorder with depressive disorders: a placebo-controlled trial.
    Guerdjikova AI; McElroy SL; Winstanley EL; Nelson EB; Mori N; McCoy J; Keck PE; Hudson JI
    Int J Eat Disord; 2012 Mar; 45(2):281-9. PubMed ID: 21744377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcome and tolerability of duloxetine in the treatment of major depressive disorder: a 12-week study with plasma levels.
    Volonteri LS; Colasanti A; Cerveri G; Fiorentini A; De Gaspari IF; Mauri MC; Valli A; Papa P; Mencacci C
    J Psychopharmacol; 2010 Aug; 24(8):1193-9. PubMed ID: 19406851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An open-label study of duloxetine hydrochloride, a mixed serotonin and noradrenaline reuptake inhibitor, in patients with DSM-III-R major depressive disorder. Lilly Duloxetine Depression Study Group.
    Berk M; du Plessis AD; Birkett M; Richardt D
    Int Clin Psychopharmacol; 1997 May; 12(3):137-40. PubMed ID: 9248869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent overeating: an empirical comparison of binge eating disorder, bulimia nervosa, and obesity.
    Fichter MM; Quadflieg N; Brandl B
    Int J Eat Disord; 1993 Jul; 14(1):1-16. PubMed ID: 8339091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypomania across the binge eating spectrum. A study on hypomanic symptoms in full criteria and sub-threshold binge eating subjects.
    Amianto F; Lavagnino L; Leombruni P; Gastaldi F; Daga GA; Fassino S
    J Affect Disord; 2011 Oct; 133(3):580-3. PubMed ID: 21621271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study.
    Nierenberg AA; Greist JH; Mallinckrodt CH; Prakash A; Sambunaris A; Tollefson GD; Wohlreich MM
    Curr Med Res Opin; 2007 Feb; 23(2):401-16. PubMed ID: 17288694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topiramate use in obese patients with binge eating disorder: an open study.
    Appolinario JC; Fontenelle LF; Papelbaum M; Bueno JR; Coutinho W
    Can J Psychiatry; 2002 Apr; 47(3):271-3. PubMed ID: 11987480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of duloxetine in the treatment of patients with borderline personality disorder: a pilot study.
    Bellino S; Paradiso E; Bozzatello P; Bogetto F
    J Psychopharmacol; 2010 Mar; 24(3):333-9. PubMed ID: 18719047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression.
    Hellerstein DJ; Stewart JW; McGrath PJ; Deliyannides DA; Batchelder ST; Black SR; Withers A; O'Shea D; Chen Y
    J Clin Psychiatry; 2012 Jul; 73(7):984-91. PubMed ID: 22901348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venlafaxine treatment of binge-eating disorder associated with obesity: a series of 35 patients.
    Malhotra S; King KH; Welge JA; Brusman-Lovins L; McElroy SL
    J Clin Psychiatry; 2002 Sep; 63(9):802-6. PubMed ID: 12363121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose escitalopram in the treatment of binge-eating disorder with obesity: a placebo-controlled monotherapy trial.
    Guerdjikova AI; McElroy SL; Kotwal R; Welge JA; Nelson E; Lake K; Alessio DD; Keck PE; Hudson JI
    Hum Psychopharmacol; 2008 Jan; 23(1):1-11. PubMed ID: 18058852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of duloxetine and selective serotonin reuptake inhibitors: comparisons as assessed by remission rates in patients with major depressive disorder.
    Thase ME; Pritchett YL; Ossanna MJ; Swindle RW; Xu J; Detke MJ
    J Clin Psychopharmacol; 2007 Dec; 27(6):672-6. PubMed ID: 18004135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An open-label trial of sibutramine in obese patients with binge-eating disorder.
    Appolinario JC; Godoy-Matos A; Fontenelle LF; Carraro L; Cabral M; Vieira A; Coutinho W
    J Clin Psychiatry; 2002 Jan; 63(1):28-30. PubMed ID: 11838622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.